-----

Welcome to the December 2011 issue of Pharmaceutical Technology Sourcing and Management, your information resource about the pharmaceutical supply chain. In this issue, the impact of the recently enacted patent-reform law on the pharmaceutical industry. Plus manufacturing considerations in producing antibody drug conjugates. And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

Global Feature
Patent Reform and the Pharmaceutical Industry: From First-to-File to Post-Grant Review and Beyond
Courtenay C. Brinckerhoff, partner of Foley & Lardner LLP and vice-chair of the firm's chemical, biotechnology and pharmaceutical practice
The author discusses the major changes in US patent laws as a result of the recently signed patent-reform law and the implications for pharmaceutical companies. >> Read More

APIs
Technical Perspectives: Antibody Drug Conjugates
A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology and editor of Sourcing and Management.
Grant E. Boldt, PhD, director of European business development for SAFC, discusses manufacturing considerations in producing antibody drug conjugates.
>> Read More

Outsourcing
Biosimilars' Technology Needs
Eric Langer, president of BioPlan Associates
Biosimilar manufacturers need better expression systems and analytical tools to compete.
>> Read More

CSR and Sustainability Forum
Pharmaceutical Technology’s dedicated editorial coverage on the developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, other business sectors, and public and private organizations. This month, we feature articles on pharmaceutical companies’ sustainability objectives and green-manufacturing projects, the World Health Organization’s progress report on combating HIV/AIDS, and a roundup of CSR and sustainability news.

Pharmaceutical Companies Target Green Manufacturing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and editor of Sourcing and Management.
A roundup of pharmaceutical companies' sustainability objectives and key green manufacturing projects. >> Read More

World Health Organization Issues Progress Report on Combating HIV/AIDS
Patricia Van Arnum, executive editor of Pharmaceutical Technology and editor of Sourcing and Management.
International efforts, including improving access to medicines, have contributed to stemming the rise of HIV/AIDS in the developing world. >> Read More

CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations. >> Read More

-----

Sourcing and Management’s Community of Experts
The panel consists of leading professionals involved in the synthesis, manufacture, and sourcing of active pharmaceutical ingredients and intermediates and experts in formulation and dosage-form manufacturing. The community of experts lends its expertise to the eNewsletter by providing reviews of technical articles as well as offering perspectives on topics of relevance to pharmaceutical manufacturers and their suppliers.
>> Read More

-----

For the full listing of calendar events, see the Calendar of Events page

December 2011
Dec. 12–14
IVT's Quality Forum for Raw Materials and Supplier Oversight
Philadelphia

February 2012
Feb. 14–17
Informex
New Orleans

March
March 12-15
DCAT Week
New York